Good morning, everyone, and how are you today? A shiny day is unfolding over the Pharmalot corporate campus, where we are scurrying to hustle the short people off to their various schoolhouses. Nothing like a marathon first thing in the morning. So we are quickly downing a cup of stimulation because there is much to do today. We know you can relate. To help you along, we have gathered a few items of interest. Hope your day goes well and stay in touch...
Reckitt Benckiser Says US Reform To Hurt Drug Unit (Bloomberg News)
Cardinal Health To Buy Canada's Futuremed (Reuters)
Momenta Says Generic Lovenox To Be Launched By Year End (Associated Press)
FDA Official Talks Up 'Smart Regulation' (Philadelphia Inquirer)
Pfizer Sued By Chinese Animal Drug Maker Over Arsenic Residue (Farmers Weekly)
WuXi Buys Two Chinese CROs (Outsourcing Pharma)
Lilly Not Interested In Buying Parts Of Abbott (Bloomberg News)
Sanofi Names David Meeker To Head Genzyme (Xconomy)
Ferring Pharmaceuticals Buys Cytokine (Pharma Times)
Pfizer Trovan Payout Lingers In Nigeria (This Day)
FDA Approves Lundbeck Epilepsy Drug (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning